Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · IEX Real-Time Price · USD
73.98
+0.51 (0.69%)
At close: May 1, 2024, 4:00 PM
74.35
+0.37 (0.50%)
Pre-market: May 2, 2024, 6:35 AM EDT

Dr. Reddy's Laboratories Revenue

In the fiscal year ending March 31, 2023, Dr. Reddy's Laboratories had annual revenue of $2.99B with 6.32% growth.

Revenue (ttm)
$2.99B
Revenue Growth
+6.32%
P/S Ratio
4.12
Revenue / Employee
$115,657
Employees
25,863
Market Cap
12.32B USD

Revenue Chart

* The company reports in INR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 20232.99B177.70M6.32%
Mar 31, 20222.81B228.76M8.85%
Mar 31, 20212.58B269.12M11.62%
Mar 31, 20202.32B92.37M4.15%
Mar 31, 20192.22B41.59M1.91%
Mar 31, 20182.18B13.23M0.61%
Mar 31, 20172.17B-165.41M-7.09%
Mar 31, 20162.33B-33.74M-1.42%
Mar 31, 20152.37B159.80M7.24%
Mar 31, 20142.21B67.36M3.15%
Mar 31, 20132.14B232.69M12.20%
Mar 31, 20121.91B231.71M13.82%
Mar 31, 20111.68B111.29M7.11%
Mar 31, 20101.56B196.93M14.40%
Mar 31, 20091.37B118.18M9.46%
Mar 31, 20081.25B-252.03M-16.78%
Mar 31, 20071.50B956.82M175.61%
Mar 31, 2006544.85M97.83M21.89%
Mar 31, 2005447.02M-16.09M-3.47%
Mar 31, 2004463.11M83.73M22.07%
Mar 31, 2003379.39M38.58M11.32%
Mar 31, 2002340.80M104.68M44.33%
Mar 31, 2001236.13M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition